MongoDB Gains 0.98% as $400M Volume Ranks 260th in U.S. Daily Liquidity

On September 26, 2025, MongoDB (MDB) closed with a 0.98% gain, marking a modest upward movement in its stock price. The company's trading volume totaled $0.4 billion, placing it 260th in terms of daily liquidity among U.S.-listed equities. The performance reflects continued investor interest in the NoSQL database provider amid broader market dynamics.

Recent developments suggest mixed signals for the company's strategic direction. A partnership announcement with a major cloud infrastructure provider highlighted MongoDB's efforts to expand its ecosystem integration capabilities. However, the lack of specific revenue-sharing terms in the collaboration has led some analysts to question the immediate financial impact of the agreement. Meanwhile, regulatory scrutiny over data privacy practices in several key markets remains unresolved, creating a degree of uncertainty for long-term growth projections.

Technical indicators show the stock has been consolidating within a defined range for the past three weeks, with key resistance levels near its 52-week high. Institutional ownership patterns indicate a slight increase in short-term hedging activity, though no major stake changes have been reported. The company's upcoming earnings release in mid-October could provide a catalyst for directional movement in the near term.

To build this back-test accurately I first need to nail down a couple of practical details that aren’t fully specified yet: 1. Market universe • Should I use all U.S. exchange-listed common stocks (NYSE + NASDAQ) or another market/universe? 2. Volume definition • “Daily trading volume” in shares, or “dollar volume” (shares × price)? 3. Entry & exit prices • Buy at that day’s close and exit at the next day’s close (close-to-close), or buy next day’s open and exit that same day’s close (open-to-close), etc. • Please confirm the exact one-day holding convention you want. 4. Transaction costs / slippage • Should I assume zero, or apply a flat commission & bid-ask spread? 5. Survivorship / delisting treatment • OK to use today’s constituent list (introduces survivorship bias), or should I use a point-in-time universe that includes delisted names? Once I have these details I can generate the data-retrieval plan, run the daily rebalancing logic, and return performance stats and visuals for 2022-01-03 through the present.